- Vatroslav Mateljic's innovative approach and commitment to
transforming the lives of patients will strengthen Takeda's
leadership position in the Canadian biopharmaceutical
sector
TORONTO, Sept. 16,
2024 /CNW/ - Takeda Canada Inc.
("Takeda Canada") is pleased
to announce the appointment of Vatroslav (Vatro) Mateljic as
its new General Manager to lead the Canadian operations of
Japan's largest pharmaceutical
company.
Mr. Mateljic has held a number of executive leadership roles in
sales, marketing and country management over his 25-year
career in the pharmaceutical industry. Most recently, he
served as Takeda's General Manager in Sweden.
"Vatro's commitment to driving business growth and implementing
strategic initiatives that positively impact patient outcomes and
organizational success make him a valuable asset for our Canadian
business," said Ricardo Marek,
President of the Europe and Canada
Business Unit at Takeda. "Canada is a critical market for Takeda's
global operations and I am confident that under Vatro's leadership,
we will strengthen our position as a leading biopharmaceutical
company in the country, delivering highly innovative medicines and
transformative care to Canadians."
Takeda is a global, values-based, R&D-driven
biopharmaceutical company with an unwavering commitment to bringing
better health and a brighter future to people around the world.
Established in Canada in 2009,
Takeda is one of the fastest-growing pharmaceutical companies in
Canada and a leader in
gastrointestinal and inflammation, rare diseases, plasma-derived
therapies, oncology, and neuroscience.
"I am delighted to have been selected to lead the Canadian
operations and work alongside the many talented individuals that
make up the Canadian team," said Vatro Mateljic. "This is an
important time for Takeda and our industry in Canada, and I look forward to ensuring
sustainable access to innovative medicines for Canadians who need
them most."
Trained as a medical doctor, Mr. Mateljic holds a medical degree
from the University of Zagreb, and
a master's in business administration (MBA) from IEDC-Bled School
of Management.
About Takeda Canada Inc.
Takeda Canada Inc. is the Canadian organization of Takeda
Pharmaceutical Company Limited (TSE: 4502/NYSE: TAK). Takeda is
focused on creating better health for people and a brighter future
for the world. We aim to discover and deliver life-transforming
treatments in our core therapeutic and business areas, including
gastrointestinal and inflammation, rare diseases, plasma-derived
therapies, oncology, neuroscience and vaccines. Together with our
partners, we aim to improve the patient experience and advance a
new frontier of treatment options through our dynamic and diverse
pipeline. As a leading values-based, R&D-driven
biopharmaceutical company headquartered in Japan, we are guided by our commitment to
patients, our people and the planet. Our employees in approximately
80 countries and regions are driven by our purpose and are grounded
in the values that have defined us for more than two centuries. For
more information,
visit: https://www.takeda.com/en-ca/
SOURCE Takeda Canada Inc.